Shares of Aveanna Healthcare Holdings Inc. (AVAH) surged 9.96% in pre-market trading on Thursday following the company's announcement of better-than-expected first-quarter results and an upward revision to its full-year 2025 guidance.
The home healthcare provider reported Q1 revenue of $559.2 million, significantly beating the analyst estimate of $513.1 million. Adjusted EBITDA came in at $67.4 million, also surpassing expectations of $39.9 million. The company's net income for the quarter stood at $5.2 million, translating to earnings per share of $0.03.
In light of the strong performance, Aveanna raised its full-year 2025 outlook. The company now expects revenue to exceed $2.15 billion, up from the previous guidance range of $2.10 - $2.12 billion. Additionally, the adjusted EBITDA guidance was increased to over $207 million, a substantial boost from the earlier projected range of $190 - $194 million. This positive revision in outlook appears to be a key driver behind the stock's pre-market rally, as investors react favorably to the improved financial prospects for the company.
免責聲明：投資有風險，本文並非投資建議，以上內容不應被視為任何金融產品的購買或出售要約、建議或邀請，作者或其他用戶的任何相關討論、評論或帖子也不應被視為此類內容。本文僅供一般參考，不考慮您的個人投資目標、財務狀況或需求。TTM對信息的準確性和完整性不承擔任何責任或保證，投資者應自行研究並在投資前尋求專業建議。